Precision medicine beyond SNPs: Tumour mutation burdens, exomes and ctDNA methylation – Scientific symposium provided by Illumina


Room: Room 2N

Sponsored by:

Speaker: Andrew Beggs, Reader in Cancer Genetics and CRUK Advanced Clinician Scientist, University of Birmingham, UK

Next-generation sequencing (NGS) has emerged as a valuable tool in cancer research, enabling the detection of somatic mutations and gene expression changes in tumor DNA at high resolution and a steady accuracy. But what is the next frontier in research? In this workshop we will present the latest data and research implemented at the University of Birmingham and how it was achieved, including: Tumor Mutation Burden (TMB) analysis, whole epigenomic analysis of ctDNA using the MethylationEPIC platform and exome sequencing of clinical FFPE samples.